Bryan Mattison And Rojek Ptrs is a
Optometrist based in Cambridge, New York. Bryan Mattison And Rojek Ptrs is licensed to practice in New York (license number VUT004160-1) and their current practice location is
15 W Main St, Cambridge, New York. It can be reached at their office (for appointments etc.) via phone at
(518) 677-5422.
NPI number for Bryan Mattison And Rojek Ptrs is 1265567812 and their current mailing address is 15 W Main St, Cambridge, New York. Bryan Mattison And Rojek Ptrs
does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1265567812.
Healthcare Provider's Profile
Full Name | Bryan Mattison And Rojek Ptrs |
---|
Type | Facility |
---|
Speciality | Optometrist |
---|
Location | 15 W Main St, Cambridge, New York |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
NPI Data:
- NPI Number: 1265567812
- Provider Enumeration Date: 02/23/2007
- Last Update Date: 05/04/2020
Medical Identifiers
Medical identifiers for Bryan Mattison And Rojek Ptrs such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1265567812 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
152W00000X | Optometrist | VUT004160-1 (New York) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bryan Mattison And Rojek Ptrs is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Bryan Mattison And Rojek Ptrs 15 W Main St, Cambridge, NY 12816-1152 Ph: (518) 677-5422 | Bryan Mattison And Rojek Ptrs 15 W Main St, Cambridge, NY 12816-1152 Ph: (518) 677-5422 |
Reviews and Comments